The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

Autor: M. Keltai, Michael Gent, A Sosa Liprandi, T. Wittlinger, Andrzej Budaj, Piotr Szymański, A Avezum, M. Galli, H. De Raedt, M. Sotty, E. G. Hasbani, J. Bouthier, S. Chrolavicius, P. J. Commerford, B. J. Gersh, N. Awan, Bongani M. Mayosi, M. Den Hartoog, F. Zhao, P. Widimsky, S. Kopecky, F. Mauri, P. Commerford, Christophe Gaudin, A. Pipilis, J. Norris, J Pogue, D. C G Basart, J. Wittes, Y. K. Chan, J. Cairns, K Hall, J. Varigos, A. Maggioni, K. Fox, A. A. Fernandez, M. Nieminen, I. Copland, T. Mocceti, J. Renkin, Akbar Panju, S. Ounpuu, P. Montague, R. J. Peters, V. Yacyshyn, J. J. Fuselli, E. Sitkei, H. Rupprecht, J. O. Bono, M. Bertrand, J. Keys, M. Flather, Sonia S. Anand, Dereck L. Hunt, T. Ryan, J. F. Marquis, Madhu K. Natarajan, Jack Hirsh, R. A. Ahuad Guerrero, W. Grossman, Robert G. Hart, P. Auger, T. Hess, C. Rihal, J. Morais, R. Diaz, Matthew J. McQueen, W. Wasek, B. Cracknell, C. Joyner, A. J. Gambarte, J. Garcia-Guerrero, B. Morris, L. Ceremuzynski, G. Tognoni, N. Karatzas, K. Malmberg, A. Caccavo, L. Piegas, C. Wright, Catherine Demers, N. Khurmi, David A. Halon, G. Allende, Vicent Valentin, E. Paolasso, R. Peters, M. A. Ramos-Corrales, M. G. Franzosi, J. Col, L. Ryden, Shamir R. Mehta, G. Wyse, B. S. Lewis, John W. Eikelboom, M. Blumenthal, Salim Yusuf

Publikováno v: European Heart Journal. 21:2033-2041

Background Other than aspirin, there are few oral antithrombotic treatments with proven efficacy in patients with acute coronary syndrome. In this report, we present the rationale, design and baseline characteristics of the Clopidogrel in Unstable an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c90fa1449354b46583dfc7753e941ea
https://doi.org/10.1053/euhj.2000.2474